Effect of pretreatment with omalizumab with or without antihistamines on the tolerability of immunotherapy in patients with asthma inadequately controlled with inhaled corticosteroids

被引：0

作者：

Panahloo, Z. ^{[1
]}

Casale, T. ^{[2
]}

Massanari, M. ^{[3
]}

Nelson, H. ^{[4
]}

Busse, W. ^{[5
]}

Kianifard, F. ^{[3
]}

Geba, G. ^{[3
]}

Zeldin, R. ^{[3
]}

机构：

[1] Novartis Horsham Res Ctr, Horsham, W Sussex, England

[2] Creighton Univ, Dept Med, Omaha, NE 68178 USA

[3] Novartis Pharmaceut, US Med, E Hanover, NJ USA

[4] Natl Jewish Hlth, Dept Med, Denver, CO USA

[5] Univ Wisconsin, Sch Med, Allergy Asthma & Immunol Clin, Madison, WI USA

来源：

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

886

引用

页码：344 / 344

页数：1